May 8, 2018 / 10:49 PM / 12 days ago

BRIEF-Melinta Therapeutics Q1 Loss Per Share $0.95

May 8 (Reuters) - Melinta Therapeutics, Inc.:

* MELINTA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.95

* Q1 REVENUE $14.8 MILLION VERSUS I/B/E/S VIEW $12.9 MILLION

* Q1 EARNINGS PER SHARE VIEW $-1.30 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below